Operating Lease, Payments of MoonLake Immunotherapeutics from 31 Dec 2022 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary: MoonLake Immunotherapeutics annual and quarterly Operating Lease, Payments in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
MoonLake Immunotherapeutics Operating Lease, Payments for the quarter ending 31 Mar 2025 was $368,000, a 1.1% increase year-over-year.
MoonLake Immunotherapeutics annual Operating Lease, Payments for 2025 was $1,555,000, a 5.4% increase from 2024.
MoonLake Immunotherapeutics annual Operating Lease, Payments for 2024 was $1,475,000, a 250% increase from 2023.
MoonLake Immunotherapeutics annual Operating Lease, Payments for 2023 was $422,000, a 180% increase from 2022.
Source SEC data: View on sec.gov

Operating Lease, Payments, Annual (USD)

Operating Lease, Payments, YoY Annual Change (%)

Operating Lease, Payments, Quarterly (USD)

Operating Lease, Payments, YoY Quarterly Change (%)

MoonLake Immunotherapeutics Annual Operating Lease, Payments (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2025	$1,555,000	+$80,000	+5.4%	01 Jan 2025	31 Dec 2025	10-K	25 Feb 2026	2025	FY
2024	$1,475,000	+$1,053,000	+250%	01 Jan 2024	31 Dec 2024	10-K	25 Feb 2026	2025	FY
2023	$422,000	+$271,350	+180%	01 Jan 2023	31 Dec 2023	10-K	25 Feb 2026	2025	FY
2022	$150,650			01 Jan 2022	31 Dec 2022	10-K	26 Feb 2025	2024	FY

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$368,000	+$4,000	+1.1%	01 Jan 2025	31 Mar 2025	10-Q	12 May 2025	2025	Q1
Q1 2024	$364,000	+$325,175	+838%	01 Jan 2024	31 Mar 2024	10-Q	12 May 2025	2025	Q1
Q1 2023	$38,825			01 Jan 2023	31 Mar 2023	10-Q	07 May 2024	2024	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.